Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 6, 2008, Pages 2089-2096

  Lawson, Mark A ^a   Jain, Sonia ^a   Sun, Shelly ^a   Patel, Ketan ^a   Malcolm, Pamela J ^a   Chang, R Jeffrey ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN; INSULIN; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; HORMONE DETERMINATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN INFUSION; LOW DRUG DOSE; METHODOLOGY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

EID: 45149086567     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2656     Document Type: Article

References (36)

1. Yen SS 1980 The polycystic ovary syndrome. Clin Endocrinol (Oxf) 12:177-207
2. Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F 1976 Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest 57:1320-1329
3. The Rotterdam ESHRE/ASRM-Sponsored PCOS concensus workshop group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41-47
4. Chang RJ, Mandel FP, Lu JK, Judd HL 1982 Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease. J Clin Endocrinol Metab 54:490-494
5. Eagleson CA, Gingrich MB, Pastor CL, Arora TK, Burt CM, Evans WS, Marshall JC 2000 Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 85:4047-4052
6. Pastor CL, Griffin-Korf ML, Aloi JA, Evans WS, Marshall JC 1998 Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 83:582-590
7. Adashi EY, Hsueh AJ, Yen SS 1981 Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology 108:1441-1449
8. Buggs C, Weinberg F, Kim E, Wolfe A, Radovick S, Wondisford F 2006 Insulin augments GnRH-stimulated LHβ gene expression by Egr-1. Mol Cell Endocrinol 249:99-106
9. Dorn C, Mouillet JF, Yan X, Ou Q, Sadovsky Y 2004 Insulin enhances the transcription of luteinizing hormone-β gene. Am J Obstet Gynecol 191:132-137
10. Dunaif A, Graf M 1989 Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. J Clin Invest 83:23-29
11. Nestler JE, Clore JN, Strauss 3rd JF, Blackard WG 1987 The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J Clin Endocrinol Metab 64:180-184
12. Mehta RV, Patel KS, Coffler MS, Dahan MH, Yoo RY, Archer JS, Malcom PJ, Chang RJ 2005 Luteinizing hormone secretion is not influenced by insulin infusion in women with polycystic ovary syndrome despite improved insulin sensitivity during pioglitazone treatment. J Clin Endocrinol Metab 90:2136-2141
13. Mortola JF, Sathanandan M, Kolterman O, Yen SCC, Insulin modulates gonadotropin release and gonadotrope sensitivity to GnRH in polycystic ovary syndrome and normal women. Proc of the 35th Annual Meeting of the Society for Gynecological Investigation, San Diego, CA, 1989 (Abstract 420, page 291)
14. Nestler JE, Jakubowicz DJ 1996 Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335:617-623
15. Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R 1996 The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:3299-3306
16. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ 1994 Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 43:647-654
17. Huber-Buchholz MM, Carey DG, Norman RJ 1999 Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 84: 1470-1474
18. Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM 2000 Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 85:2767-2774
19. Butzow TL, Lehtovirta M, Siegberg R, Hovatta O, Koistinen R, Seppala M, Apter D 2000 The decrease in luteinizing hormone secretion in response to weight reduction is inversely related to the severity of insulin resistance in overweight women. J Clin Endocrinol Metab 85:3271-3275
20. Hasegawa I, Murakawa H, Suzuki M, Yamamoto Y, Kurabayashi T, Tanaka K 1999 Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome. Fertil Steril 71:323-327
21. Velazquez E, Acosta A, Mendoza SG 1997 Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol 90:392-395
22. Cataldo NA, Abbasi F, McLaughlin TL, Basina M, Fechner PY, Giudice LC, Reaven GM 2006 Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome. Hum Reprod 21:109-120
23. Pasquali R, Casimirri F, De Iasio R, Mesini P, Boschi S, Chierici R, Flamia R, Biscotti M, Vicennati V 1995 Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. J Clin Endocrinol Metab 80:654-658
24. Evans WS, Taylor AE, Boyd DG, Johnson ML, Matt DW, Jimenez Y, Nestler JE 2007 Lack of effect of short-term diazoxide administration on luteinizing hormone secretion in women with polycystic ovary syndrome. Fertil Steril 88:118-124
25. Patel K, Coffler MS, Dahan MH, Yoo RY, Lawson MA, Malcom PJ, Chang RJ 2003 Increased luteinizing hormone secretion in women with polycystic ovary syndrome is unaltered by prolonged insulin infusion. J Clin Endocrinol Metab 88:5456-5461
26. Patel K, Coffler MS, Dahan MH, Malcom PJ, Deutsch R, Chang RJ 2004 Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 60:67-74
27. Arroyo A, Laughlin GA, Morales AJ, Yen SS 1997 Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab 82:3728-3733
28. Pagan YL, Srouji SS, Jimenez Y, Emerson A, Gill S, Hall JE 2006 Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions. J Clin Endocrinol Metab 91:1309-1316
29. Schneider JE 2004 Energy balance and reproduction. Physiol Behav 81:289-317
30. Nawrocka J, Starczewski A 2007 Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance. Gynecol Endocrinol 23:231-237
31. Chang RJ, Coffler MS 2007 Polycystic ovary syndrome: early detection in the adolescent. Clin Obstet Gynecol 50:178-187
32. Blank SK, McCartney CR, Marshall JC 2006 The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum Reprod Update 12:351-361
33. Laughlin GA, Morales AJ, Yen SS 1997 Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia. J Clin Endocrinol Metab 82:1692-1696
34. Iuorno MJ, Islam LZ, Veldhuis PP, Boyd DG, Farhy LS, Johnson ML, Nestler JE, Evans WS 2007 Leptin secretory burst mass correlates with body mass index and insulin in normal women but not in women with polycystic ovary syndrome. Metabolism 56:1561-1565
35. Ludwig AK, Weiss JM, Tauchert S, Dietze T, Rudolf S, Diedrich K, Peters A, Oltmanns KM 2007 Influence of hypo- and hyperglycaemia on plasma leptin concentrations in healthy women and in women with polycystic ovary syndrome. Hum Reprod 22:1555-1561
36. Xita N, Papassotiriou I, Georgiou I, Vounatsou M, Margeli A, Tsatsoulis A 2007 The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers. Metabolism 56:766-771